Lang Coleman
Chief Executive Officer chez Alamo CBD LLC
Fortune : 1 318 $ au 31/03/2024
Profil
Lang Coleman is currently the Chief Executive Officer at Alamo CBD LLC.
Prior to this, he worked as a Director at Indoor Harvest Corp.
from 2017 to 2022 and as a Professor at St. Philip's College from 1998 to 2015.
Coleman received his undergraduate and graduate degrees from Austin Peay State University and his doctorate from the University of Kansas.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
INDOOR HARVEST CORP
0,05% | 31/12/2022 | 1 317 528 ( 0,05% ) | 1 318 $ | 31/03/2024 |
Postes actifs de Lang Coleman
Sociétés | Poste | Début |
---|---|---|
Alamo CBD LLC
Alamo CBD LLC BiotechnologyHealth Technology Part of Indoor Harvest Corp., Alamo CBD LLC is a private company that produces and supplies cannabis for medical purposes. The company is based in Selma, TX. Lang Coleman has been the CEO of the company since 2017. Alamo CBD was acquired by Indoor Harvest Corp. on August 23, 2017 for $1.52 million. | Chief Executive Officer | 01/03/2017 |
Anciens postes connus de Lang Coleman
Sociétés | Poste | Fin |
---|---|---|
INDOOR HARVEST CORP. | Director/Board Member | 14/06/2022 |
St. Philip's College | Corporate Officer/Principal | 01/05/2015 |
Formation de Lang Coleman
Austin Peay State University | Graduate Degree |
University of Kansas | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
INDOOR HARVEST CORP. | Producer Manufacturing |
Entreprise privées | 1 |
---|---|
Alamo CBD LLC
Alamo CBD LLC BiotechnologyHealth Technology Part of Indoor Harvest Corp., Alamo CBD LLC is a private company that produces and supplies cannabis for medical purposes. The company is based in Selma, TX. Lang Coleman has been the CEO of the company since 2017. Alamo CBD was acquired by Indoor Harvest Corp. on August 23, 2017 for $1.52 million. | Health Technology |